Business · 10/06/2021Updated: 10/17/2026 · 1 min read
FDA Renews Medical Imaging Drugs Advisory Committee for 2 Years
Summary
The FDA has renewed the Medical Imaging Drugs Advisory Committee for an additional 2 years, with the new charter set to expire on May 18, 2023, following a determination by the Commissioner of Food and Drugs that it is in the public interest to do so.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →